173 related articles for article (PubMed ID: 23065408)
1. Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.
Gerds AT; Scott BL
Curr Hematol Malig Rep; 2012 Dec; 7(4):292-9. PubMed ID: 23065408
[TBL] [Abstract][Full Text] [Related]
2. [New therapeutic possibilities for acquired clonal blood diseases and myelodysplasia].
Brinch L; Evensen SA; Hammerstrøm J; Blichfeldt P
Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2343-5. PubMed ID: 1412233
[TBL] [Abstract][Full Text] [Related]
3. [Allogeneic bone marrow transplantation in adult patients with serious hematological diseases 1985-1992].
Brinch L; Evensen SA; Blomhoff JP; Albrechtsen D
Tidsskr Nor Laegeforen; 1993 Nov; 113(27):3351-3. PubMed ID: 8273060
[TBL] [Abstract][Full Text] [Related]
4. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
[TBL] [Abstract][Full Text] [Related]
5. Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Selleri C; Serio B; Risitano AM
Mini Rev Med Chem; 2011 Jun; 11(6):536-43. PubMed ID: 21561402
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
7. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit Engraftment.
DeZern AE; Jones RJ; Brodsky RA
Biol Blood Marrow Transplant; 2018 Dec; 24(12):e26-e30. PubMed ID: 30055352
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
10. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
11. [Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome: a case report].
Wang XJ; Chen L; Sai Y
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):563. PubMed ID: 22338185
[No Abstract] [Full Text] [Related]
12. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
[TBL] [Abstract][Full Text] [Related]
13. Severe aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome in a patient with non-A-E hepatitis virus infection.
Shaaban H; Gauchan D; Kahlon A; Maroules M
Ann Hepatol; 2014; 13(4):466-7. PubMed ID: 24927620
[No Abstract] [Full Text] [Related]
14. Unusual Anemias.
Daughety MM; DeLoughery TG
Med Clin North Am; 2017 Mar; 101(2):417-429. PubMed ID: 28189179
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.
Shasheleva DA; Maschan AA; Shelikhova LN; Petrova UN; Kurnikova EE; Illarionova OI; Boyakova EV; Novichkova GA; Maschan MA
Ter Arkh; 2018 Aug; 90(7):57-64. PubMed ID: 30701923
[TBL] [Abstract][Full Text] [Related]
18. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
[TBL] [Abstract][Full Text] [Related]
20. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
